Title: Martine Jandrot-Perrus: Innovator in Thrombosis Treatment
Introduction
Martine Jandrot-Perrus is a notable inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the treatment of thrombosis. Although she currently holds no granted patents, her work is recognized for its potential impact on patient care.
Latest Patent Applications
Martine Jandrot-Perrus has filed a patent application titled "Pharmaceutical Compositions for the Treatment of Thrombosis in Patients Suffering from a Myeloproliferative Neoplasm." This application addresses the critical issue of thrombosis, which is a leading cause of morbidity and mortality in patients with JAK2V617F positive myeloproliferative neoplasms (MPN). The application highlights the role of JAK2V617F endothelial cells in promoting thrombosis through the induction of endothelial P-selectin expression. The invention proposes a method of treating thrombosis by administering a therapeutically effective amount of a P-selectin antagonist to affected patients.
Conclusion
Martine Jandrot-Perrus is an influential figure in the medical research community, focusing on innovative solutions for thrombosis treatment. Her ongoing work and patent applications reflect her commitment to advancing healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.